- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 19 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.4: 2 residues within 4Å:- Chain A: N.312, Q.561
Ligand excluded by PLIPNAG.5: 1 residues within 4Å:- Chain A: N.597
Ligand excluded by PLIPNAG.6: 3 residues within 4Å:- Chain A: N.690
- Chain B: I.775, Y.777
Ligand excluded by PLIPNAG.7: 3 residues within 4Å:- Chain A: N.698, L.903, Q.907
Ligand excluded by PLIPNAG.8: 2 residues within 4Å:- Chain A: N.782, Q.785
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain A: A.687, K.1054, N.1055
Ligand excluded by PLIPNAG.10: 1 residues within 4Å:- Chain A: N.1115
Ligand excluded by PLIPNAG.11: 2 residues within 4Å:- Chain B: N.597, T.599
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain B: N.690
- Chain C: I.775, Y.777
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain B: N.698, L.903, Q.907
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain B: N.782, S.784
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain B: A.687, E.1053, N.1055
- Chain C: Q.876
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain B: N.1115
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain C: N.597, Q.625
Ligand excluded by PLIPNAG.18: 4 residues within 4Å:- Chain A: I.775, Y.777
- Chain C: S.689, N.690
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain C: N.698, Q.907
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain C: N.782, S.784, Q.785
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain C: A.687, N.1055
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain C: N.1115
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Modjarrad, K. et al., Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine. Npj Vaccines (2024)
- Release Date
- 2024-12-04
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 19 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Modjarrad, K. et al., Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine. Npj Vaccines (2024)
- Release Date
- 2024-12-04
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C